VR Logo

Dare Bioscience Inc. (DARE) download report


Healthcare | Biotechnology & Pharma Research

Dare Bioscience Inc. (DARE) Premium Coverage

52 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Daré Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in the identifying, developing, and marketing products for women's health in the United States.

IPO Date: 10-Apr-2014

Pres, CEO, Sec. & Director: Ms. Sabrina Martucci Johnson

Chief Financial Officer: Ms. Lisa Walters-Hoffert

Listing: NASDAQ: DARE

Country: United States

Headquarters: San Diego, CA

Website: https://www.darebioscience.com

Key Facts

Market cap: $116.90 Mln

Revenue (TTM): $0.00 Mln

Earnings (TTM): $-39.77 Mln

Cash: $39.32 Mln

Total Debt: $1.21 Mln

Insider's Holding: 1.96%

Liquidity: Low

52 Week range: $0.92 - 2.51

Shares outstanding: 84,711,296

10 Years Aggregate:

  • CFO: $-28,937.53 Mln
  • EBITDA: $-66,604.95 Mln
  • Net Profit: $-66,280.84 Mln

Stock Performance

Time Period Dare Bioscience (DARE) S&P BSE Sensex* S&P Small-Cap 600*
YTD-36.50-8.97-18.40
1 month9.48-3.38-8.42
3 months-17.53-7.93-14.06
1 Year-24.850.55-17.64
3 Years14.1010.416.75
5 Years-20.8011.456.18
10 Years--12.0510.23
As on 28-Jun-2022 *As on 29-Jun-2022
Year Dare Bioscience (DARE) S&P Small-Cap 600 S&P BSE Sensex
202149.2525.2721.99
202063.419.5715.75
201915.4120.8614.38
2018-66.97-9.705.87
2017-69.4411.7327.91
2016-74.7124.741.95
2015-54.98-3.36-5.03